| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 27, 2007
Accepted on December 6, 2007
Northwest Lipid Metabolism and Diabetes Research Laboratories, University of Washington School of Medicine, Seattle, WA, Centers for Disease Control and Prevention, Atlanta, GA, Wake Forest University School of Medicine, Winston-Salem, NC, Pacific Health Research Institute, Honolulu, HI, University of South Carolina, Columbia, SC, University of Southern California, Los Angeles, CA, Children's Hospital and Regional Medical Center, Seattle, WA, Children's Hospital Medical Center, Cincinnati, OH, University of Colorado Health Sciences Center, Denver, CO
* To whom correspondence should be addressed. E-mail: smm{at}u.washington.edu.
Aims: To assess the prevalence and determinants of elevated apolipoprotein B (apoB) and dense LDL in United States youth with type 1 or type 2 diabetes.
Methods: Cross-sectional analyses of apoB concentrations, LDL density, and prevalence of elevated apoB levels and of dense LDL from the SEARCH for Diabetes in Youth study, a six-center United States-based study of youth with diabetes onset < 20 years of age (2,657 with type 1 and 345 with type 2).
Results: Among youth with type 1 diabetes, 11% had elevated apoB (
100 mg/dL, 1.95 mM/L), 8% had dense LDL [relative flotation rate (Rf)
0.237], and 12% had elevated LDL-cholesterol (
130 mg/dL, 3.36 mM/L). In contrast, among youth with type 2 diabetes, 36% had elevated apoB, 36% had dense LDL, but only 23% had elevated LDL-cholesterol. Dense LDL and apoB each increased with HbA1c in both types. Among type 1 diabetics in poor glycemic control (HbA1c
9.5%), 28% had elevated apoB and 18% had dense LDL, while 72% of poorly controlled type 2 diabetics had elevated apoB and 62% had dense LDL.
Conclusions: In youth with type 1 diabetes, elevated apoB and dense LDL were not highly prevalent, while elevated apoB and dense LDL were common lipoprotein abnormalities in youth with type 2 diabetes. The prevalence of these risk factors substantially increased with poor glycemic control in both groups, stressing the importance of achieving and maintaining an optimal glucose control.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |